Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Dantzer

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Endocrinology|July 17, 2004
Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramideKlemen Strle, Suzanne R Broussard, Robert H McCusker, et al.
The European Journal of Neuroscience|November 1, 2008
Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in miceRozenn Mingam, Aurélie Moranis, Rose-Marie Bluthé, et al.
Pain|July 9, 2010
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signalingHanneke L D M Willemen, Niels Eijkelkamp, Huijing Wang, et al.
Psychoneuroendocrinology|February 8, 2018
Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorderAlan R Prossin, Matthew Chandler, Kelly A Ryan, et al.
Brain, Behavior, and Immunity|February 1, 2015
Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in miceWenjun Zhou, Robert Dantzer, David P Budac, et al.
Brain, Behavior, and Immunity|August 29, 2012
Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient miceAngela W Corona, Diana M Norden, John P Skendelas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2007
Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune systemJonathan P Godbout, Maïté Moreau, Jacques Lestage, et al.
Brain, Behavior, and Immunity|October 11, 2014
Advancing the understanding of behaviors associated with Bacille Calmette Guérin infection using multivariate analysisSandra L Rodriguez-Zas, Scott E Nixon, Marcus A Lawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2016
Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized TrialJulie Lasselin, Michael T Treadway, Tamara E Lacourt, et al.
Brain, Behavior, and Immunity|May 20, 2020
Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigueAaron J Grossberg, Elisabeth G Vichaya, Phillip S Gross, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Endocrinology|July 17, 2004
Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramideKlemen Strle, Suzanne R Broussard, Robert H McCusker, et al.
The European Journal of Neuroscience|November 1, 2008
Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in miceRozenn Mingam, Aurélie Moranis, Rose-Marie Bluthé, et al.
Pain|July 9, 2010
Microglial/macrophage GRK2 determines duration of peripheral IL-1beta-induced hyperalgesia: contribution of spinal cord CX3CR1, p38 and IL-1 signalingHanneke L D M Willemen, Niels Eijkelkamp, Huijing Wang, et al.
Psychoneuroendocrinology|February 8, 2018
Functional TSPO polymorphism predicts variance in the diurnal cortisol rhythm in bipolar disorderAlan R Prossin, Matthew Chandler, Kelly A Ryan, et al.
Brain, Behavior, and Immunity|February 1, 2015
Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in miceWenjun Zhou, Robert Dantzer, David P Budac, et al.
Brain, Behavior, and Immunity|August 29, 2012
Indoleamine 2,3-dioxygenase inhibition attenuates lipopolysaccharide induced persistent microglial activation and depressive-like complications in fractalkine receptor (CX(3)CR1)-deficient miceAngela W Corona, Diana M Norden, John P Skendelas, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 14, 2007
Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune systemJonathan P Godbout, Maïté Moreau, Jacques Lestage, et al.
Brain, Behavior, and Immunity|October 11, 2014
Advancing the understanding of behaviors associated with Bacille Calmette Guérin infection using multivariate analysisSandra L Rodriguez-Zas, Scott E Nixon, Marcus A Lawson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|September 14, 2016
Lipopolysaccharide Alters Motivated Behavior in a Monetary Reward Task: a Randomized TrialJulie Lasselin, Michael T Treadway, Tamara E Lacourt, et al.
Brain, Behavior, and Immunity|May 20, 2020
Interleukin 6-independent metabolic reprogramming as a driver of cancer-related fatigueAaron J Grossberg, Elisabeth G Vichaya, Phillip S Gross, et al.
Pageof 22